Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.
about
Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetesIn vitro and in vivo models for the study of oral delivery of nanoparticlesUse of lectin-functionalized particles for oral immunotherapyA review of the efficacy and safety of nanoparticle-based oral insulin delivery systemsCurrent advances in research and clinical applications of PLGA-based nanotechnology.Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.Intraoral film containing insulin-phospholipid microemulsion: formulation and in vivo hypoglycemic activity study.Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex.The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability.Synthesis and characterization of multifunctional hybrid-polymeric nanoparticles for drug delivery and multimodal imaging of cancer.Self-assembled lecithin/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation.Nanotechnology safety concerns revisited.A Long-Acting BMP-2 Release System Based on Poly(3-hydroxybutyrate) Nanoparticles Modified by Amphiphilic Phospholipid for Osteogenic DifferentiationNanoparticle strategies for the oral delivery of insulin.Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.Improved oral bioavailability of 20(R)-25-methoxyl-dammarane-3β, 12β, 20-triol using nanoemulsion based on phospholipid complex: design, characterization, and in vivo pharmacokinetics in rats.Pharmacosomes: the lipid-based new drug delivery system.Challenges and advances in nanoparticle-based oral insulin delivery.Design of oral insulin delivery systems.Microencapsulation techniques to develop formulations of insulin for oral delivery: a review.Emerging micro- and nanotechnology based synthetic approaches for insulin delivery.Cyclodextrin and phospholipid complexation in solubility and dissolution enhancement: a critical and meta-analysis.Novel drug delivery system: an immense hope for diabetics.A review of biodegradable polymeric systems for oral insulin delivery.Polymer-based vehicles for therapeutic peptide delivery.PEG-lipid-PLGA hybrid nanoparticles loaded with berberine-phospholipid complex to facilitate the oral delivery efficiency.Formulation, characterization and evaluation of the effect of polymer concentration on the release behavior of insulin-loaded Eudragit(®)-entrapped mucoadhesive microspheres.Sustained Administration of β-cell Mitogens to Intact Mouse Islets Ex Vivo Using Biodegradable Poly(lactic-co-glycolic acid) Microspheres.Design of high payload PLGA nanoparticles containing melittin/sodium dodecyl sulfate complex by the hydrophobic ion-pairing technique.Novel quaternized chitosan and polymeric micelles with cross-linked ionic cores for prolonged release of minocycline.A novel approach for antibody nanocarriers development through hydrophobic ion-pairing complexation.Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec).Lyophilized oral sustained release polymeric nanoparticles of nateglinide.Development and evaluation of pharmacosomes of aceclofenac.The study on the entrapment efficiency and in vitro release of puerarin submicron emulsion.Comparative study on the suitability of two techniques for measuring the transfer of lipophilic drug models from lipid nanoparticles to lipophilic acceptors.Single-step assembly of polymer-lipid hybrid nanoparticles for mitomycin C delivery.Semi-interpenetrating network (sIPN) co-electrospun gelatin/insulin fiber formulation for transbuccal insulin delivery.Chitosan nanofibers for transbuccal insulin delivery.
P2860
Q26779447-DBC7AD1E-7FD8-4254-A377-97B3388B52A1Q26829514-86524AF2-F76E-4673-B496-61CA65A0F9A4Q26849550-FBC37CED-E901-447F-B5D1-04460943CA39Q26999867-4DE1414C-D2AF-4C44-B109-92BAE78E18F8Q30482916-E6A00463-4CA3-4941-B52E-63C1F41904C1Q33510791-478E2868-7C9C-4A6D-A24F-4AE8F40BD752Q34733812-8F234253-F3C0-4208-89EA-568A220E474FQ35523352-F8B3FF94-685E-4868-8043-CD506DFBA31EQ35677172-032652F5-014E-4743-8426-6EB8F4C8662AQ35750616-A6755E03-1E09-4915-90CD-A7830C7502F6Q36078293-C3871AC8-A305-4237-B252-EE4EA90C6954Q36631567-D7F1CE92-6684-404E-BD48-6C0A257B6E84Q36865560-06F3F44A-B71D-434E-A8F8-110B62DBCA62Q37030550-0E035DBB-2093-4C5B-893D-E57D3D0FAF21Q37039026-0B50EF59-3112-4C0C-A4FE-49502B75BCF1Q37278642-C1627BD7-E7FA-4E50-AFC4-AEB32B0FC7EFQ37412939-87244917-E592-4CFB-8A86-59498A09122FQ37515443-E35D3218-FAD1-4FC7-BD44-E8E14D36526AQ37632407-340F35BB-EF24-4427-9BE5-F9EDF35752B1Q37646752-230AA239-E6F0-48EB-B366-96F94010AB84Q38066966-EBE13A93-9E5F-4249-B11A-B303B2DB730FQ38195730-4D41CE83-34E0-42D7-90A4-365FD02167E9Q38218602-64687D5A-0972-4A04-884B-621BDF4592B1Q38302000-271AB33A-07CB-4BFA-B0C9-66F709906220Q38525280-F508056A-422D-4AA7-AA8F-CFE6FEF2919BQ38645362-E3A48DDA-F8BC-42C8-AB3F-7A489D90C11EQ38783341-F4B11629-94AA-400B-9E24-07ADD8543B41Q39147137-3C9BF800-46CE-48E6-84B4-8C47D0C55F28Q39189248-E0475EE7-6F6B-4E6A-8669-78A0508BFCB3Q39875051-17FB3DDF-41E6-4894-A670-0C9F1EF08542Q39902170-33E89DE5-5D19-4CA8-8D86-C31F01A3EB74Q39903748-9999A614-9419-44C7-89E1-F1955F712340Q40728949-439C8D88-8341-4ED2-BF5B-E1020B1E31A8Q41770111-7E02E268-C064-4B02-9712-6B12F8D65A89Q41777699-C6F8B70F-6396-4071-B87A-E1E28E705044Q41989290-D18D3BDE-1608-43E5-8030-D6F27042FF40Q42075019-66D8972B-8DD0-4AA7-BA21-7D8ADAF2EB93Q42117333-CC0E3829-99A4-4927-A33C-78655FD0D657Q42799577-9CC48BA0-F966-4244-9BC5-E4D74F2F48F2Q42804461-937D1109-CB5D-430A-8DE2-D43D2E373A4E
P2860
Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Biodegradable nanoparticles lo ...... zation and in vivo evaluation.
@en
Biodegradable nanoparticles lo ...... zation and in vivo evaluation.
@nl
type
label
Biodegradable nanoparticles lo ...... zation and in vivo evaluation.
@en
Biodegradable nanoparticles lo ...... zation and in vivo evaluation.
@nl
prefLabel
Biodegradable nanoparticles lo ...... zation and in vivo evaluation.
@en
Biodegradable nanoparticles lo ...... zation and in vivo evaluation.
@nl
P2093
P921
P1476
Biodegradable nanoparticles lo ...... zation and in vivo evaluation.
@en
P2093
Liqiang Zhang
Yoshiaki Kawashima
P304
P356
10.1016/J.JCONREL.2006.05.013
P407
P577
2006-05-24T00:00:00Z